Liu Z - Search Results

1

PARPi treatment enhances radiotherapy-induced ferroptosis and antitumor immune responses via the cGAS signaling pathway in colorectal cancer.

Shen D, Luo J, Chen L, Ma W, Mao X, Zhang Y, Zheng J, Wang Y, Wan J, Wang S, Ouyang J, Yi H, Liu D, Huang W, Zhang W, Liu Z, McLeod HL, He Y. Shen D, et al. Among authors: liu z, liu d. Cancer Lett. 2022 Dec 1;550:215919. doi: 10.1016/j.canlet.2022.215919. Epub 2022 Sep 16. Cancer Lett. 2022. PMID: 36116741

2

Effect of the CYP2C9*3 allele on lornoxicam metabolism.

Liu YL, Zhang W, Tan ZR, Ouyang DS, Luo CH, Liu ZQ, Qiu Y, Chen Y, He YJ, Zhou G, Zhou HH. Liu YL, et al. Clin Chim Acta. 2006 Feb;364(1-2):287-91. doi: 10.1016/j.cca.2005.07.013. Epub 2005 Sep 22. Clin Chim Acta. 2006. PMID: 16182270

3

Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males.

Zhang W, Yu BN, He YJ, Fan L, Li Q, Liu ZQ, Wang A, Liu YL, Tan ZR, Fen-Jiang, Huang YF, Zhou HH. Zhang W, et al. Clin Chim Acta. 2006 Nov;373(1-2):99-103. doi: 10.1016/j.cca.2006.05.010. Epub 2006 May 13. Clin Chim Acta. 2006. PMID: 16784736

4

Effect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinide.

Zhang W, He YJ, Han CT, Liu ZQ, Li Q, Fan L, Tan ZR, Zhang WX, Yu BN, Wang D, Hu DL, Zhou HH. Zhang W, et al. Br J Clin Pharmacol. 2006 Nov;62(5):567-72. doi: 10.1111/j.1365-2125.2006.02686.x. Epub 2006 Jun 23. Br J Clin Pharmacol. 2006. PMID: 16796707 Free PMC article.

5

Organic anion transporting polypeptide-1B1 haplotypes in Chinese patients.

Xu LY, He YJ, Zhang W, Deng S, Li Q, Zhang WX, Liu ZQ, Wang D, Huang YF, Zhou HH, Sun ZQ. Xu LY, et al. Acta Pharmacol Sin. 2007 Oct;28(10):1693-7. doi: 10.1111/j.1745-7254.2007.00643.x. Acta Pharmacol Sin. 2007. PMID: 17883959

6

OATP1B1 polymorphism is a major determinant of serum bilirubin level but not associated with rifampicin-mediated bilirubin elevation.

Zhang W, He YJ, Gan Z, Fan L, Li Q, Wang A, Liu ZQ, Deng S, Huang YF, Xu LY, Zhou HH. Zhang W, et al. Among authors: liu zq. Clin Exp Pharmacol Physiol. 2007 Dec;34(12):1240-4. doi: 10.1111/j.1440-1681.2007.04798.x. Clin Exp Pharmacol Physiol. 2007. PMID: 17973861 Clinical Trial.

7

Inhibition of ADP-induced platelet aggregation by clopidogrel is related to CYP2C19 genetic polymorphisms.

Chen BL, Zhang W, Li Q, Li YL, He YJ, Fan L, Wang LS, Liu ZQ, Zhou HH. Chen BL, et al. Clin Exp Pharmacol Physiol. 2008 Aug;35(8):904-8. doi: 10.1111/j.1440-1681.2008.04915.x. Epub 2008 Mar 13. Clin Exp Pharmacol Physiol. 2008. PMID: 18346178

8

Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes.

Liu HL, Lin YG, Wu J, Sun H, Gong ZC, Hu PC, Yin JY, Zhang W, Wang D, Zhou HH, Liu ZQ. Liu HL, et al. Eur J Clin Pharmacol. 2008 Jul;64(7):663-71. doi: 10.1007/s00228-008-0483-9. Epub 2008 Apr 26. Eur J Clin Pharmacol. 2008. PMID: 18438653

9

Evidence for an effect of clozapine on the regulation of fat-cell derived factors.

Yang Z, Yin JY, Gong ZC, Huang Q, Chen H, Zhang W, Zhou HH, Liu ZQ. Yang Z, et al. Among authors: liu zq. Clin Chim Acta. 2009 Oct;408(1-2):98-104. doi: 10.1016/j.cca.2009.07.021. Epub 2009 Aug 11. Clin Chim Acta. 2009. PMID: 19682446

10

Effects of the peroxisome proliferator activated receptor-γ coactivator-1α (PGC-1α) Thr394Thr and Gly482Ser polymorphisms on rosiglitazone response in Chinese patients with type 2 diabetes mellitus.

Zhang KH, Huang Q, Dai XP, Yin JY, Zhang W, Zhou G, Zhou HH, Liu ZQ. Zhang KH, et al. J Clin Pharmacol. 2010 Sep;50(9):1022-30. doi: 10.1177/0091270009355159. Epub 2010 May 24. J Clin Pharmacol. 2010. PMID: 20498286

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90,277 results

Search Page

Filters